Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2160 (LINC02160)

Target
LINC02160
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2160 (LINC02160) is an autonomously transcribed RNA gene longer than 200 nucleotides that does not overlap annotated coding genes. It belongs to the class of long intergenic non-coding RNAs (lincRNAs), which are known in general to regulate chromatin structure, transcription, and genome architecture, typically with high tissue specificity[5][1][3]. There is no specific data regarding LINC02160's function, clinical utility, therapeutic targeting, or disease association. Like many lincRNAs, its biological roles are inferred from its molecular class—possible regulation of neighboring genes, modulation of chromatin and transcription, and involvement in fine-tuning gene expression[5]. LINC02160 is cataloged in major gene databases (GeneCards, BioGPS, NCBI Gene), but its functional characterization and clinical relevance remain unknown[1][3].

Other names
LINC02160
02

Biological functions

Chromatin remodeling (general for lncRNAs)Regulation of transcription (general for lncRNAs)RNA stabilization (general for lncRNAs)Specific biological functions for LINC02160 remain uncharacterized; these are typical for the molecular class.
03

Disease associations

Other (no direct evidence for involvement in cancer, inflammation, or other diseases per available sources)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2160 (LINC02160).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2160 (LINC02160).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call